Cite
Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review.
MLA
Wu, Weixin, et al. “Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review.” PLoS ONE, vol. 10, no. 3, Mar. 2015, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0122047.
APA
Wu, W., Liu, X., Chaftari, P., Cruz Carreras, M. T., Gonzalez, C., Viets-Upchurch, J., Merriman, K., Tu, S.-M., Dalal, S., & Yeung, S.-C. J. (2015). Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review. PLoS ONE, 10(3), 1–17. https://doi.org/10.1371/journal.pone.0122047
Chicago
Wu, Weixin, Xiandong Liu, Patrick Chaftari, Maria Teresa Cruz Carreras, Carmen Gonzalez, Jayne Viets-Upchurch, Kelly Merriman, Shi-Ming Tu, Shalini Dalal, and Sai-Ching J. Yeung. 2015. “Association of Body Composition with Outcome of Docetaxel Chemotherapy in Metastatic Prostate Cancer: A Retrospective Review.” PLoS ONE 10 (3): 1–17. doi:10.1371/journal.pone.0122047.